![]() |
市场调查报告书
商品编码
1394056
北美男用保险套市场预测至 2028 年 - 按材料、产品类型和分销管道进行的区域分析North America Male Condom Market Forecast to 2028 - Regional Analysis By Material, Product Type, and Distribution Channels |
北美男用保险套市场预计将从2022年的19.7953亿美元成长到2028年的30.5625亿美元。预计2022年至2028年CAGR为7.5%。
北美男用保险套市场性传染感染病例上升
性传染感染(STI)对全世界的性健康和生殖健康有重大影响。根据世界卫生组织 (WHO) 的数据,该地区每天有超过 100 万人感染性传染感染。每年报告约 3.76 亿新感染披衣菌、淋病、梅毒和滴虫病。避孕方法会改变感染性传染感染的风险。避孕套可在一定程度上防止细菌和病毒感染。
美国最常见的性传染感染是人类乳突病毒或 HPV。根据美国国家生物技术资讯中心(NCBI)发表的一篇文章,80%的性活跃族群被感染,其中18-59岁年龄层的人感染率为42%; 7%的人患有口腔HPV;每年报告约 1400 万新病例。这种情况非常常见,以至于美国疾病管制中心 (CDC) 估计,几乎所有未接种疫苗的性活跃人士最终都会被感染。 HPV 通常是无症状的,尤其是男性,但它可能会引起性病和肛门生殖器疣。 CDC 确定 2020 年美国报告了约 240 万例非 HPV 相关性传染感染。披衣菌是其中最常见的病例,有 160 万例。此外,2020年通报淋病病例677,769例,较2016年增加45%;通报第一期及二期梅毒133,945例,较同期增加52%。总体而言,美国性传染感染的总体发生率正在上升,预计到2022 年将出现250 万例或更多性传染感染病例。因此,性传染感染病例的增加以及政府倡议提高人们对性传染病的认识将在预测中推动男用安全套市场的发展这段时期正在推动北美男用避孕套市场的成长。
北美男用保险套市场概况
在北美,美国占有男用保险套市场的重要份额。该国市场的成长主要是由于节育意识的增强而推动的。根据美国疾病管制与预防中心2019年美国青少年危险行为调查,最近一次性交时使用保险套的比例为54.3%,保险套是美国最普遍使用的主要避孕措施。
性传染病的日益普及是该地区市场的主要驱动因素。根据美国疾病管制与预防中心 (CDC) 的数据,2018 年,美国五分之一(6,800 万人)患有 STI(性传染感染),其中 2018 年新增 STI 病例 2,600 万例。计划生育方面的努力可能有利于市场成长。 50多年来,美国政府始终支持计划生育/生殖健康(FP/RH)工作,是全球计划生育/生殖健康的最大贡献者。它是全球最大的避孕药具分销商和买家之一。 2019 年,美国政府向联合国人口基金(UNFPA) 提供的FP/RH 资金为6.08 亿美元。美国卫生与公共服务部(HHS) 推出了一项青少年怀孕预防计划,其中包括针对高风险青少年怀孕群体的计划。政府为青少年怀孕预防计画投入了 1 亿美元赠款,以解决青少年怀孕和性活动率高的问题,增加避孕措施的使用,减少性传染感染 (STI) 并增加保险套的使用。
在美国推出的产品数量不断增加可能会推动预测期内的市场成长。 2022 年,FDA 批准了第一个专门用于肛交的保险套。这种保险套将帮助使用者最大限度地减少肛交过程中的性传染感染。所有年龄层的需求激增推动了该地区的市场成长。
北美男用保险套市场收入及 2028 年预测(百万美元)
北美男用保险套市场细分
北美男用保险套市场按产品类型、材料、分销管道和国家细分。
依产品类型,北美男用保险套市场分为调味保险套、镶钉保险套、保暖保险套、愉悦保险套等。 2022年,风味细分市场在北美男用保险套市场中占据最大份额。根据材料,北美男用保险套市场分为乳胶和非乳胶。 2022年,乳胶细分市场在北美男用保险套市场中占据较大份额。根据配销通路,北美男士保险套市场分为药局/药局、超市/大卖场、线上药局等。 2022年,药局/药局细分市场在北美男用保险套市场中占据最大份额。根据国家/地区,北美男用保险套市场分为美国、加拿大和墨西哥。 2022年,美国将主导北美男用保险套市场。Reckitt Benckiser Group Plc、Okamoto Industries Inc、Karex Bhd、Church & Dwight Co Inc和Humanwell Healthcare Group Co Ltd是北美男用保险套市场上的一些领先公司。
The North America male condom market is expected to grow from US$ 1,979.53 million in 2022 to US$ 3,056.25 million by 2028. It is estimated to grow at a CAGR of 7.5% from 2022 to 2028.
Rising Cases of Sexually Transmitted Infections in North America Male Condom Market
Sexually transmitted infections (STIs) have a major impact on sexual and reproductive health worldwide. As per the World Health Organization (WHO), more than 1 million people acquire STIs every day regionally. Each year, ~376 million new infections with chlamydia, gonorrhea, syphilis, and trichomoniasis are reported. Contraceptive methods alter the risk of acquiring STIs. Condoms provide a certain level of protection from bacterial and viral infections.
The most common STI in the US is the human papillomavirus or HPV. As per an article published in National Center for Biotechnology Information (NCBI), 80% of sexually active people are infected, including 42% of people in the 18-59 age group; 7% of people have oral HPV; and approximately 14 million new cases are reported yearly. It is so common that the Centers for Disease Control (CDC) estimates that virtually all sexually active persons who are not vaccinated will eventually become infected. HPV is often asymptomatic, especially in men, but it may cause venereal and anogenital warts. The CDC has determined that ~2.4 million non-HPV-related STIs were reported in the US in 2020. Chlamydia was the most common of these at 1.6 million cases. Moreover, 677,769 cases of gonorrhea were reported in 2020, up 45% from 2016, and 133,945 cases of primary and secondary syphilis, up 52% over the same period. In general, the overall rate of STIs is increasing in the US, with 2.5 million STD cases or more expected to occur in 2022. Thus, rising cases of STI's and growing awareness about STDs through government initiatives will drive the market for male condoms in forecast period is driving the growth of the North America Male Condom Market.
North America Male Condom Market Overview
In North America, the US holds a significant share of the male condoms market. The growth of the market in the country is primarily driven by the increasing awareness of birth control. As per the Centers for Diseases Control and Prevention youth risk behavior survey US 2019, the condom use at last sexual intercourse was 54.3%, and condoms were the most prevalent primary contraceptive used in the United States.
The growing prevalence of sexually transmitted diseases is the major driving factor for the market in the region. According to the Centers for Disease Control and Prevention (CDC), in 2018, one in five (68 million) people in the US had an STI (sexually transmitted infection), of which 26 million cases were new STIs in 2018. Also, government efforts for family planning are likely to favor market growth. The government of the US has always supported family planning/reproductive health (FP/RH) efforts for more than 50 years and is the largest contributor to family planning/reproductive health globally. It is one of the largest distributors and buyers of contraceptives worldwide. The US government funds for FP/RH to the United Nations Population Fund (UNFPA) was US$ 608 million in 2019. The Department of Health and Human Services (HHS) introduced a Teen Pregnancy Prevention Initiative comprising programs targeting high-risk teen pregnancy groups. The government invested USD 100 million in grant funding for the Teen Pregnancy Prevention Program to address high rates of teen pregnancy and sexual activity, increase the usage of contraception, reduce sexually transmitted infections (STIs), and increase the use of condoms.
An increasing number of product launches in the US is likely to propel market growth during the forecast period. In 2022, FDA approved the first condom specifically intended for anal sex. This condom will help users to minimize sexually transmitted infections during anal sex. An upsurge in demand among all age groups drives the market growth in this region.
North America Male Condom Market Revenue and Forecast to 2028 (US$ Million)
North America Male Condom Market Segmentation
The North America male condom market is segmented into product type, material, and distribution channels, and country.
Based on product type, the North America male condom market is segmented into flavored condom, studded, warming, pleasured, and others. The flavored segment held the largest share of the North America male condom market in 2022. Based on material, the North America male condom market is segmented into latex and non-latex. The latex segment held a larger share of the North America male condom market in 2022. Based on distribution channel, the North America male condom market is segmented into drug stores/ pharmacies, supermarkets/ hypermarkets, online pharmacies, and others. The drug stores/ pharmacies segment held the largest share of the North America male condom market in 2022. Based on country, the North America male condom market is segmented into the US, Canada, and Mexico. The US dominated the North America male condom market in 2022. Reckitt Benckiser Group Plc, Okamoto Industries Inc, Karex Bhd, Church & Dwight Co Inc, and Humanwell Healthcare Group Co Ltd are some of the leading companies operating in the North America male condom market.